Table 2. Baseline characteristics according to secondary endpoint.
| Characteristic | Met secondary endpoint n = 32 | Did not meet secondary endpoint n = 60 | P |
|---|---|---|---|
| Age years | 58.6 (20.1) | 57.8 (16.9) | 0.296 |
| BMI kg/m2 | 26.9 (9.6) | 28.9 (7.4) | 0.861 |
| Female sex | 9 (28.1%) | 19 (31.7%) | 0.725 |
| Hypertension | 9 (28.1%) | 22 (36.7) | 0.409 |
| Diabetes Mellitus | 5 (15.6%) | 4 (6.7%) | 0.168 |
| IHD | 2 (6.3%) | 3 (5.0%) | 0.801 |
| Non-PAF | 12 (37.5%) | 18 (30.0%) | 0.465 |
| Time since 1st AF diagnosis months | 34.4 (29.6) | 32.7 (34.8) | 0.641 |
| CHA2DS2VASc > = 2 | 11 (34.4%) | 24 (40.0%) | 0.597 |
| Mean LA Pressure >11mmHg | 17 (53.1%) | 39 (65.0%) | 0.384 |
| Mean RA Pressure >6mmHg | 18 (56.3%) | 25 (41.7%) | 0.152 |
| LA volume / BSA >28ml | 20 (62.5%) | 31 (51.7%) | 0.261 |
| LA diameter / BSA >23 mm | 5 (15.6) | 4 (6.6%) | 0.151 |
| LV EDV / BSA >75 ml | 0 (0.0%) | 2 (3.3%) | 0.325 |
| LV EF <55% | 4 (12.5%) | 4 (6.7%) | 0.276 |
| Mean PIIINP pg/ml (n = 69) | 51.9 (100.2) | 39.6 (78.74) | 0.492 |
| Mean ICTP ng/ml (n = 79) | 290.8 (267.2) | 333.7 (344.9) | 0.114 |
| CS ICTP ng/ml (n = 76) | 305.7 (163.2) | 328.4 (275.8) | 0.829 |
| Mean gal-3 ng/ml (n = 81) | 36.1 (75.4) | 24.1 (35.3) | 0.938 |
| LA gal-3 ng/ml (n = 81) | 17.7 (47.5) | 26.1 (31.6) | 0.888 |
| Mean FGF-23 pg/ml (n = 33) | 34.5 (29.6) | 46.8 (60.7) | 0.808 |
| LA low voltage >30.0%, all participants (n = 92) | 11 (34.4%) | 12 (20.0%) | 0.129 |